Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

What is the Tumor Microenvironment?

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Research

British Pioneers in Cancer Biology

What is Cancer of Unknown Primary?

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Acidosis and Tumor Progression

What Role do Biobanks Play in Cancer Research?

Investigating the Molecular Mechanisms of Cancer

Caring for a Loved One with Cancer

Cancer Prognosis

See more featured articles »

Cancer Prevention: Lowering your Risk

Assay for Monitoring and Treating Malignant Brain Tumors

What is Cancer?

Cancer History

Cancer Glossary

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cutaneous Manifestations of Internal Malignancy

Is Cancer a Metabolic Disorder?

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Exploiting Enzymes in Cancer Diagnosis and Therapy

Hot vs Cold: the differences between tumor types

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Symptoms

The Biochemistry of Breast Cancer Screening

Microfluidic cancer treatment screen combined with flow cytometry

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Classification

CDK9 and Cancer

What Causes Cancer?

Insights into Oncofertility

Cancer Pain

Targeted Cancer Therapies

Secondary Lung Cancer

Secondary Brain Cancer

Effects of Social and Economic Deprivation on Cancer Mortality

Using Biomarkers to Detect Cancer

Pediatric Cancer

Transforming Cancer Care through Genomic Testing

Cancer Management

Cancer Pain Management

What is Tumorigenesis?

Insight into Cancer Vaccines

Cancer Epidemiology

Hypoxia Markers and Their Importance

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Extracellular Vesicles as Floating Cancer Biomarkers

Overview of Cell Viability and Cytotoxicity

Why are Cancer Cell Lines Useful?

Myc Mutations and Cancer

The Effects of Cancer on Family Life

What is Immunochemotherapy?

Living with Cancer Pain

Cancer Pathophysiology

The Cancer Cell Surface Proteome as a Therapeutic Target

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Diagnosis

What is Merkel Cell Carcinoma?

Latest Cancer News and Research

New strategy to fight chronic kidney inflammation

Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells – also known as "zombie cells" – in diabetic kidney disease.

10 Mar 2026

Adelaide University decodes the secrets of cancer survival

A new study led by researchers at Adelaide University and published in Science Advances has revealed why some cancers can grow and survive in the body, while others cannot.

10 Mar 2026

Using engineered bacteria to breach tumor defenses

Baylor University researchers have published a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S. VanNieuwenhze, Ph.D., FRSC, University Distinguished Professor and chair of the Department of Biology, along with Baylor doctoral students and a colleague at Texas Tech University Health Sciences Center, published their promising research in Cell Chemical Biology.

10 Mar 2026

Blood protein structure changes may reveal early signs of Alzheimer’s

Alzheimer's disease affects an estimated 7.2 million Americans age 65 and older, according to the Alzheimer's Association.

9 Mar 2026

Scientists simulate complete life cycle of a minimal bacterial cell

By simulating the life cycle of a minimal bacterial cell - from DNA replication to protein translation to metabolism and cell division - scientists have opened a new frontier of computer vision into the essential processes of life.

9 Mar 2026

AI model flags hidden breast cancers years before diagnosis in routine mammograms

Researchers evaluated four deep learning models using over 112,000 negative screening mammograms from the UK NHS to determine how well artificial intelligence could predict future breast cancers missed during routine screening. The MIT-developed Mirai model performed best, identifying about 27.5% of interval cancers within the top 4% of women flagged as highest risk.

9 Mar 2026

Microbial ecosystems influence success of cancer checkpoint immunotherapy

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies.

9 Mar 2026

Patients with advanced cancer want involvement in treatment decisions

Patients with advanced cancer should be involved in decisions about their own treatment. Yet, patients, and relatives and nurses too, are often unsure how exactly this should take place, according to a new doctoral thesis from the University of Agder (UiA).

9 Mar 2026

STING agonists exert potent antitumor effects against nervous system tumors

The cGAS-STING signaling pathway has emerged as a major focus in cancer immunotherapy because it stimulates interferon production and enhances antitumor immune responses.

9 Mar 2026

Boron neutron capture therapy shows promise for deadly brain tumors

Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival.

9 Mar 2026

Daily multivitamin intake linked to slower biological aging in older adults

An analysis led by Mass General Brigham investigators found slower aging in older adults after two years of a daily multivitamin, with greater benefits for those who began the trial with accelerated biological age.

9 Mar 2026

Women face higher liver fibrosis risk from cardiometabolic factors than men

Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater increase in risk for liver fibrosis than men with the same risk factors.

9 Mar 2026

Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients' bleeding or clotting risks, despite previous lab results that raised alarms.

9 Mar 2026

Unmasking the hyperactive circuitry of early Alzheimer’s

Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease.

9 Mar 2026

New peptide fragments teach the gut to tolerate food

In little moments like when sipping coffee or licking an ice cream cone, it doesn't seem like your body is pulling off a biological miracle. But it is. That cookie is not you-yet when you put it in your mouth, your body is able to tolerate it and process it without any detriment to your health in a process called oral tolerance. How does the human body make that decision between tolerance and rejection?

9 Mar 2026

Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit

A large cohort study of more than 600,000 US veterans with type 2 diabetes found that initiating GLP-1 receptor agonists was associated with lower risks of developing substance use disorders compared with SGLT-2 inhibitors. Among veterans with existing substance use disorders, GLP-1 receptor agonist use was also linked to fewer overdose events, hospitalizations, and suicide-related outcomes.

8 Mar 2026

How somatic mutations shape disease and reveal new drug targets

Researchers reviewed how somatic mutations accumulate in normal and diseased tissues, showing that natural selection can expand clones that influence disease risk, tissue adaptation, or cellular resilience. The study proposes somatic genomics as a powerful strategy to uncover disease mechanisms and identify new therapeutic targets across multiple conditions.

8 Mar 2026